TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Midday Report: Biogen Lifts Biotech; U.S. Stocks Break Higher
Play
STOCKS

Biogen Beats Third-Quarter Earnings, Cuts Guidance

  • By Rob Lenihan
  • Oct 21, 2020 1:41 PM EDT
PRESS RELEASES

Mylan And Pfizer Receive Clearance From The U.S. Federal Trade Commission For Proposed Combination Of Mylan And Upjohn

  • By PR Newswire
  • Oct 30, 2020 1:39 PM EDT
PRESS RELEASES

Mylan And Pfizer Receive Clearance From The U.S. Federal Trade Commission For Proposed Combination Of Mylan And Upjohn

  • By Business Wire
  • Oct 30, 2020 1:22 PM EDT
Midday Report: Biogen Lifts Biotech; U.S. Stocks Break Higher
STOCKS

Biogen Beats Third-Quarter Earnings, Cuts Guidance

  • By Rob Lenihan
  • Oct 21, 2020 1:41 PM EDT
PRESS RELEASES

Mylan And Development Partner, Synthon, Win Significant European Patent Office Ruling Related To Copaxone® 40mg/mL

  • By PR Newswire
  • Sep 15, 2020 7:15 AM EDT
PRESS RELEASES

Mylan And Pfizer Receive European Commission Approval For Proposed Combination Of Mylan And Upjohn

  • By PR Newswire
  • Sep 15, 2020 7:00 AM EDT
PRESS RELEASES

Mylan To Present At The Morgan Stanley Virtual 18th Annual Global Healthcare Conference

  • By PR Newswire
  • Sep 9, 2020 1:07 PM EDT
PRESS RELEASES

Mylan To Present At The BofA Securities Virtual Global Healthcare Conference

  • By PR Newswire
  • Sep 9, 2020 1:05 PM EDT
Mylan (MYL) Stock Slides, Clinton Criticizes 'Bad Corporate Actors'
INVESTING

Mylan Will Buy Aspen Pharmacare's Thrombosis Business

  • By Vidhi Choudhary
  • Sep 8, 2020 3:13 PM EDT
PRESS RELEASES

Mylan To Acquire Aspen's Thrombosis Business In Europe

  • By PR Newswire
  • Sep 8, 2020 2:00 AM EDT
PRESS RELEASES

Mylan Brings Critical Access To The Multiple Sclerosis Community By Launching A More Affordable Treatment Option Through A First Generic To Tecfidera®

  • By PR Newswire
  • Aug 19, 2020 7:00 AM EDT
PRESS RELEASES

ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Mylan N.V. Investors Of Important Deadline In Securities Class Action - MYL

  • By PR Newswire
  • Aug 12, 2020 3:38 PM EDT
PRESS RELEASES

Mylan And Sesame Workshop Partner To Provide Socio-Emotional Support Resources To Families Impacted By COVID-19

  • By PR Newswire
  • Aug 12, 2020 9:00 AM EDT
PRESS RELEASES

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Reminds Mylan N.V. Investors Of Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - MYL

  • By Business Wire
  • Aug 9, 2020 1:15 PM EDT
New York Stock Exchange Lead
MARKETS

Gold, Moderna, Qualtrics, Coronavirus: 5 Things You Must Know

  • By Joseph Woelfel
  • Jul 27, 2020 7:50 AM EDT
PRESS RELEASES

ROSEN, A TOP RANKED INVESTOR FIRM, Reminds Mylan N.V. Investors Of Important August 25 Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - MYL

  • By PR Newswire
  • Jul 21, 2020 6:40 PM EDT
PRESS RELEASES

MYL SHAREHOLDERS: August 25, 2020 Filing Deadline In Class Action - Contact Lieff Cabraser

  • By Business Wire
  • Jul 14, 2020 9:00 AM EDT
PRESS RELEASES

MYL INVESTORS: August 25, 2020 Filing Deadline In Class Action - Contact Lieff Cabraser

  • By Business Wire
  • Jul 10, 2020 9:00 AM EDT
PRESS RELEASES

Mylan And Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval Of Hulio® (adalimumab-fkjp)

  • By PR Newswire
  • Jul 9, 2020 6:30 AM EDT
PRESS RELEASES

Mylan Secures Regulatory Approval For Remdesivir Lyophilized Powder For Injection 100 Mg/vial In India For Restricted Emergency Use In COVID-19 Patients

  • By PR Newswire
  • Jul 6, 2020 6:00 AM EDT
PRESS RELEASES

ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Reminds Mylan N.V. Investors Of Important August 25 Deadline In Securities Class Action - MYL

  • By Business Wire
  • Jul 4, 2020 4:40 PM EDT
PRESS RELEASES

MYL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Mylan N.V. Investors With Losses Exceeding $11,000,000 Of Class Action And Lead Plaintiff Deadline: August 25, 2020

  • By PR Newswire
  • Jul 3, 2020 11:00 AM EDT
PRESS RELEASES

MYL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Mylan N.V. Investors Of Class Action And Lead Plaintiff Deadline: August 25, 2020

  • By Business Wire
  • Jul 1, 2020 11:00 AM EDT
PRESS RELEASES

ROSEN, A LONGSTANDING AND TOP RANKED GLOBAL INVESTOR FIRM, Announces Filing Of Securities Class Action Lawsuit Against Mylan N.V.; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - MYL

  • By PR Newswire
  • Jun 30, 2020 7:50 PM EDT
PRESS RELEASES

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Mylan N.V. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

  • By Business Wire
  • Jun 30, 2020 10:00 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.